Cargando…
The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow
To test whether the product of the bcl-2 proto-oncogene blocks clonal deletion of self-reactive B cells, we have generated transgenic mice carrying the bcl-2 gene and the immunoglobulin genes for the anti- erythrocyte 4C8 antibody. In these transgenic mice, clonal deletion of self-reactive immature...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191192/ https://www.ncbi.nlm.nih.gov/pubmed/8376932 |
Ejemplares similares
-
Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa
Publicado: (1989) -
Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self- reactive T cells
Publicado: (1996) -
Similar rates of production of T and B lymphocytes in the bone marrow
Publicado: (1995) -
Receptor editing in self-reactive bone marrow B cells
Publicado: (1993) -
Distinct fates of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymus
Publicado: (1990)